What is the normal value of the neutrophil-to-lymphocyte ratio?

PubWeight™: 0.79‹?›

🔗 View Article (PMID 28057051)

Published in BMC Res Notes on January 03, 2017

Authors

Patrice Forget1,2, Céline Khalifa3, Jean-Philippe Defour4, Dominique Latinne4, Marie-Cécile Van Pel5, Marc De Kock3

Author Affiliations

1: Department of Anesthesiology, Cliniques Universitaires Saint-Luc, Institute of Neuroscience (pole CEMO), Université Catholique de Louvain, 1200, Brussels, Belgium. forgetpatrice@yahoo.fr.
2: Department of Anesthesiology and Perioperative Medicine, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan, 101, 1090, Brussels, Belgium. forgetpatrice@yahoo.fr.
3: Department of Anesthesiology, Cliniques Universitaires Saint-Luc, Institute of Neuroscience (pole CEMO), Université Catholique de Louvain, 1200, Brussels, Belgium.
4: Department of Clinical Biology, Cliniques Universitaires Saint-Luc, 1200, Brussels, Belgium.
5: CESI-Prévention et Protection ASBL, Brussels, Belgium.

Articles cited by this

Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol (2005) 4.92

A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer (2011) 3.59

Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother (2008) 3.32

Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol (2011) 2.89

Establishing reference intervals for clinical laboratory test results: is there a better way? Am J Clin Pathol (2010) 2.78

High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res (2010) 2.50

Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol (2011) 2.10

The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma. Eur J Cancer (2011) 1.80

Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J (2007) 1.80

Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer. Anticancer Res (2011) 1.41

Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma. World J Surg (2011) 1.36

Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy. Int J Colorectal Dis (2011) 1.21

Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison. Eur J Surg Oncol (2010) 1.13

Neutrophil-lymphocyte ratio as a predictor of major adverse cardiac events among diabetic population: a 4-year follow-up study. Angiology (2012) 1.12

Neutrophil-to-lymphocyte ratio as a predictor of acute appendicitis. Ulus Travma Acil Cerrahi Derg (2014) 1.02

Neutrophil-to-lymphocyte ratio has a close association with gangrenous appendicitis in patients undergoing appendectomy. Int Surg (2013) 0.98